Ryoji Sugiyama

NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma.

Tomoya Yamaguchi, Shuta Tomida, Kiyoshi Yanagisawa, 2012, Cancer cell.

Proteasomal non‐catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas

Hidemi Goto, Shuta Tomida, Toshiyuki Takeuchi, 2011, Molecular carcinogenesis.

Proteasomal non‐catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas

Y. Yatabe, S. Tomida, Takashi Takahashi, 2011, Molecular carcinogenesis.